Nick is an associate in the Commercialisation team, advising on commercial and regulatory matters within the life sciences and healthcare sector.
Nick has experience working on a range of matters that includes the commercialisation of intellectual property rights, resolving contractual issues, undertaking corporate due diligence and responding to regulatory and compliance questions.
Biopharma partnering monthly update: August 2024
by Nicholas Vollers and Adrian Toutoungi
Spotlight on medical devices: FDA, MHRA and EU Commission approaches to medical device regulations
by multiple authors
by multiple authors
by multiple authors
by multiple authors
by Manon van Weezel and Maarten Rijks
by Bram Nijhof and Nick Strous
by Fabio Lo Iacono and Louise Popple